This site complies with the HONcode standard for trustworthy health information:
verify here.

Rewarding for
you and us
Defeat Diabetes Foundation

Defeat Diabetes
Foundation
150 153rd Ave,
Suite 300
Madeira Beach, FL 33708

About Diabetes » Insulin Resistance

Search our News Articles Archives for diabetes and health news. Search by word or phrase. The latest article will appear first.

Metabolic Syndrome Predicts Breast Cancer Recurrence

Posted: Friday, July 21, 2006

Metabolic syndrome, especially if associated with elevated testosterone, is "an important prognostic factor" in the recurrence of breast cancer, In a small study 50% of the women with metabolic syndrome developed breast cancer recurrence.

Impaired Glucose Tolerance Raises Risk of Stroke in TIA Patients

Posted: Friday, July 14, 2006

Impaired glucose tolerance is independently linked to an elevated stroke risk in non-diabetic patients who have already experienced a TIA or minor stroke.

Impaired Fasting Glucose Screening Could Prevent Cardiovascular Disease

Posted: Friday, July 14, 2006

Finding people with impaired fasting glucose -- a prediabetic stage -- could also help identify those with risk factors that can be modified to reduce the risk of cardiovascular disease.

A1c A Better Screening Tool for Diabetes and Prediabetes Than Oral Glucose

Posted: Friday, July 14, 2006

A high normal A1c (HbA1c) reading might be a better, cheaper, and easier-to-use screening tool for prediabetes and diabetes than the laboratory-based oral glucose tolerance test (OGTT).

Sanofi's Acomplia (rimonabant) Weight Loss Drug Gets EU Approval

Posted: Friday, July 07, 2006

The European Commission has approved 20-mg tablets of rimonabant for use as an adjunct to diet and exercise in the treatment of obese or overweight patients with associated cardiometabolic risk factors such as type 2 diabetes or dyslipidemia.

Study Shows New Non-Invasive Device Screens Diabetes Better Than Fasting Plasma Glucose Test

Posted: Friday, June 30, 2006

Researchers reported a new non-invasive technology that uses fluorescent light to detect the presence of abnormal concentrations of diabetes-related biological markers found in skin was able to significantly outperform fasting plasma glucose (FPG) as a screening test for pre-diabetes and type 2 diabetes.

Few Willing to Pay to Reduce Diabetes Risk

Posted: Friday, June 30, 2006

Most people at high risk of developing type 2 diabetes are willing to participate in a risk-reduction program, but few are willing to pay full price to do so.

New Test for Insulin Resistance

Posted: Friday, June 23, 2006

Lowering blood levels of a protein found in higher quantities among those with insulin resistance might cut the risk of diabetes, metabolic syndrome and cardiovascular disease, a new study suggests. Raised levels of the protein in the blood may provide an early warning sign of the development of type 2 diabetes.

Study Shows New Non-Invasive Device Screens Diabetes Better Than Fasting Plasma Glucose Test

Posted: Thursday, June 15, 2006

Diabetes biomarkers found in skin shown to Correlate well with diabetes risk.

One-Third of Adults With Diabetes Still Don't Know They Have It

Posted: Friday, June 02, 2006

The prevalence of diagnosed diabetes in U.S. adults age 20 and older has risen from about 5.1% to 6.5%, according to researchers at the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC).